ALTSTATION.IO

KKR & Co. Inc. (KKR) Stock Analysis

By Nova Skye | AltStation.io | Updated September 19, 2026

Price
$101.28
Change
-2.70%
Market Cap
$93.54B
Avg Volume
4.4M

Company Overview

KKR & Co. Inc. is a global asset management powerhouse headquartered in New York, operating within the financial services sector. Founded on May 1, 1976, the firm makes money by pooling capital to acquire, finance, and manage companies across private equity, real estate, credit, and infrastructure. They sell fund products, co-investment opportunities, and direct deal access to institutional clients and high-net-worth investors. Put simply, KKR buys established businesses, secures operational influence or control, and later sells them for a profit.

KKR is an undisputed market leader in private equity and alternative assets rather than a niche operator. Its primary edge is global reach across North America, Europe, Asia Pacific, and the Middle East, combined with deep balance-sheet flexibility that spans debt, PIPE transactions, and mega-cap take-privates. In its middle-market private equity strategy, the firm specifically targets companies with enterprise values between $200 million and $1,000 million and EBITDA between $50 million and $250 million. Its ongoing challenge is navigating intense industry-wide competition to deploy capital at attractive valuations without sacrificing return targets.

The firm runs a patient capital model, typically holding portfolio investments for five to seven years or longer before exiting through initial public offerings, secondary offerings, or strategic sales. KKR continues to expand its mandate into impact investing, credit special situations, real estate securities, and energy infrastructure assets. Geographically, it pairs large controlling buyouts in the United States and Europe with strategic minority and consortium-led investments in Asia. KKR remains built to capture upside across every phase of the corporate lifecycle, from growth equity to distressed turnarounds.

Key Financials
Market Cap
$93.54B
Revenue
$25.83B
EBITDA
N/A
Gross Margin
54.8%
Profit Margin
12.2%
Revenue Growth
7.8%
Total Cash
$47.56B
Total Debt
$56.16B
Free Cash Flow
N/A


52-Week Price Performance Analysis

Price Statistics
P/E Ratio
32.36
Forward P/E
13.67
Beta
1.79
52-Week High
$152.10
52-Week Low
$82.67
EPS
$3.13
50-Day Avg
$103.21
200-Day Avg
$105.57
Price/Book
3.19
KKR 52-Week Stock Chart
Technical Analysis
KKR trades at $101.28, just 27% of the way from its 52-week low of $82.35 to its high of $151.01. The stock is 33.20% below that high but remains 22.49% above the low. Momentum is weak, with declines of 5.22% over five trading days and 9.04% over 20 trading days. The price is 6.75% below its 20-day moving average of $108.17. Near-term support sits at $100.79, while resistance is $115.30.


Recent News and Developments

KKR shares slide 6.37% in four sessions

KKR closed at $100.87 on September 10, down 3.09% for the day. The stock fell from $107.73 on September 4, extending its losing streak to four trading sessions. Source: StockAnalysis.com

KKR private-credit redemption pressure eases

Withdrawal requests at KKR-Income Trust I fell to roughly 2.5% of net asset value in the third quarter. The fund plans to pay $34.7 million in third-quarter redemptions plus $10.5 million carried over from the second quarter. Source: MT Newswires

Integer deal puts KKR at center of healthcare buyouts

A September 8 analysis identified KKR’s $5.89 billion agreement to acquire Integer Holdings as August’s largest private-equity transaction. Healthcare attracted $8.27 billion, or 37.4% of global private-equity investment, during the month. Source: Benzinga



Market Sentiment and Analyst Recommendations

Bull Case
KKR has scale, with $796 billion in assets under management and $331 billion in credit and liquid strategies. Assets under management have grown at an 18% compound annual rate, giving the company a strong base for future fee growth. Revenue is $25.83 billion and is growing 7.8%. KKR is also deploying serious capital, including its $5.89 billion agreement to acquire Integer Holdings. Healthcare represented $8.27 billion, or 37.4%, of global private-equity investment during the referenced month, putting that deal in an active category. Employees own roughly 30% of outstanding KKR stock, creating meaningful alignment with outside shareholders. The $127.98 analyst target sits above the $101.28 share price, and the consensus recommendation is buy across 20 analysts.
Bear Case
The chart is clearly bearish in the short term. KKR is down 5.22% over five trading days, down 9.04% over 20 trading days, and trades 6.75% below its 20-day moving average. The stock is also sitting close to its $100.79 near-term support, so another break lower would weaken the setup further. A P/E ratio of 32.36 leaves little room for disappointing growth or weaker investment performance. Total debt of $56.16 billion exceeds total cash of $47.56 billion, making balance-sheet discipline important. Private-credit liquidity remains a risk even though withdrawal requests at KKR Income Trust I declined to roughly 2.5% of net asset value. The fund still plans to pay $34.7 million in third-quarter redemptions plus $10.5 million carried over from the second quarter.
What to Watch
First, watch whether KKR holds the $100.79 near-term support after closing at $100.87 on September 10. A recovery above the $108.17 moving average would be the first sign that short-term momentum is improving. The next major technical test is $115.30, the 30-day high and current resistance level. Investors should monitor whether revenue growth holds near 7.8% and whether assets under management continue building from $796 billion. Private-credit withdrawals also matter: third-quarter requests were roughly 2.5% of net asset value, with $34.7 million scheduled for payment and another $10.5 million carried over. Watch for updates on the $5.89 billion Integer Holdings agreement and KKR’s exposure to healthcare buyouts. A break below $100.79 would strengthen the bear case, while a move through $115.30 would materially improve the chart.
Analyst Consensus
BUY

Based on 20 analyst opinions
Low Target
$105.00
Mean Target
$127.98
High Target
$166.00


Earnings and Financial Data

Sector
Financial Services
Industry
Asset Management
Employees
5,043
Earnings & Dividends
Next Earnings
Nov 05, 2026
EPS (Trailing)
$3.13
Dividend Yield
75.0%
Payout Ratio
24.0%

Frequently Asked Questions

Is KKR a good stock to buy?
The consensus recommendation is buy based on 20 analysts, and the average target is $127.98 versus a current price of $101.28. The takeaway is that analysts see upside, but the technical trend is currently weak.
What is KKR’s price target?
The average analyst target is $127.98, with estimates ranging from $105.00 to $166.00. The takeaway is that even the low end of the range is above the current $101.28 price.
Is KKR stock overvalued?
KKR trades at a P/E ratio of 32.36 while revenue growth is 7.8%. The takeaway is that the valuation demands continued growth and leaves less room for disappointment.
How strong is KKR’s balance sheet?
KKR reports $47.56 billion in total cash and $56.16 billion in total debt, alongside $25.83 billion in revenue. The takeaway is that KKR has substantial liquidity, but debt is higher than cash.
What are KKR’s support and resistance levels?
Near-term support is $100.79, and near-term resistance is $115.30. The takeaway is that holding support is critical because the stock is already 6.75% below its $108.17 20-day moving average.

Related Stock Reports

Disclaimer: This report is for informational purposes only and does not constitute financial advice. The analysis and opinions expressed are those of AltStation.io and should not be relied upon as the sole basis for investment decisions. Always conduct your own research and consult with a qualified financial advisor before making investment decisions. Past performance does not guarantee future results. Updated September 19, 2026.